- how it works : - Imagine you can create apples, and that you are the only one in the world able to do that. - So if you create 100 apples, you will make them more rare and unique, so maybe you can sell them for 10$ each one. - So now imagine you create 10,000,000,000 apples, you will have more apples than peoples need to eat, so you will have to sell your...
After correctly giving you the Bitcoin and Chainlink bottom, I think it's time to look at some other alt coin opportunities. One project I'm definitely bullish on is Quant Network: $QNT. Very low max supply of around 14M coins, no inflation but above all currently heavily involved in Project Rosalind, a joint experimentation of the Bank of England and The Bank...
It is only a great transaction of wealth, there is a decadent power fall, rises another (cantillon effect gold based). 🤫 The market only plays with everyone, analyze the 'market cap' instead of the 'price', the price no longer matters, the colored paper loses value every second. 🧙♂️ Each pillar in this world has been structurally damaged or destroyed, only to...
With a similar situation emerging to the 2008 financial crisis wherein gold and the stock market along with many other assets depreciated simultaneously, and Coronavirus creating a more risk averse investing atmosphere, The best trade to take now is to wait for a pullback to 1450 (likely entry) or 1400. The long term trend line shows that gold will find support...
The NASDAQ Biotech has just broken the monthly support line with bearish divergence. Bear marketing coming soon?
As soon as the red solid channel breaks. it's time to party. www.zacks.com
It's a buy those who doesn't like to go short IBB www.zacks.com
Biotech stocks had tremendous runs over the last few years. Many advancing several hundred percent. But all good things in the stock market come to end, and the biotech group is no exception. The advance over the last four to five years clearly reflected the improved growth rates that we saw biotech companies deliver over those years, and current fundamentals...
Waiting for entry on trigger. Preferred to be closing below 68.73 on the daily or below 69.78 after 7th December 2015. Needs permission from S&P. < 2069. Same double top pattern seen too, will probably move only after NPF or FOMC.
When something is unclear up close, it is often more attainable from a broader perspective. Rarely do traders look at the big picture when evaluating a trend. What people dont know about the DXY is that it has travelled to much higher price ranges than its current treading grounds. When we look at a large time scale, we see that the recent USD rally is a lot less...
Left chart: Combine leveraged ETF BIS (bear, bio x3) with XIV (or safer ZIV or SPLV) for a good deal on risk vs return. Right chart: BIS about to overtake EDZ (short emerging markets, x3 ETF). Ratio: 1) currently 1.5 shares of BIS to every 1 share of XIV. This ratio changes over a period of days so must be monitored closely. 2) For less volatile combo's using...
How far can this ponzi really go? Will biotech change the world forever? Is it really different this time? Short it after it breaks the curve. This could go up for another 42%, who knows how many greater fool are there still.. • BIS UltraShort Nasdaq Biotechnology 2x: etfdb.com • BIB Ultra Nasdaq Biotechnology 2x: etfdb.com • LABD Daily S&P Biotech Bear 3x...
4-22 Could It Be? Is this where we carve out a double bottom? If so then IBB (longside) MAY be carving out a double top. Remember, going long this is gaining short exposure in the bios. BIIB (Biogen) reports so be aware it could have an impact on this issue. Chart wise its all about an upside crossover of the green line. Feel free to follow on TWTR...
BIS attracted quite a few buyers when the companion BIS went parabollic and had a small blow off. But the channel held and now all those buyers will be seeking exits in the coming weeks.
There will be many of you who continue to hold onto biotech chasing even more gains refusing to believe the run is over. In the words of the great Oscar Gamble, "They don't think it be like it is, but it do." All great runs come to an end. The time to go short is at hand.
Dear fellow traders ! Eurozone shows some weaknesses to keep a strong Euro. As we already know European politicians seem a bit confused about a way to fight unemployment and inflation rates at the same time. But a decreasing euro price could leads to a nice increase of external demand to European goods and stimulate exportation. Moreover the international...